Showing results (231-240 of 285) with videos related to
Sort By:
Pageof 29
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 28, 2012
An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirinEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Journal of Hepatology|May 28, 2013
Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapyEiichi Ogawa, Norihiro Furusyo, Makoto Nakamuta, et al.Journal of Hepatology|April 2, 2013
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis CNorihiro Furusyo, Eiichi Ogawa, Makoto Nakamuta, et al.Journal of Hepatology|October 27, 2012
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter studyEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Internal Medicine (Tokyo, Japan)|March 21, 2015
Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infectionAkira Kawano, Eiichi Ogawa, Norihiro Furusyo, et al.World Journal of Gastroenterology|September 17, 2010
Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis CMosaburo Kainuma, Norihiro Furusyo, Eiji Kajiwara, et al.European Journal of Dermatology : EJD|August 29, 2006
Incidence of atopic dermatitis in nursery school children - a follow-up study from 2001 to 2004, Kyushu University Ishigaki Atopic Dermatitis Study (KIDS)Noriko Fukiwake, Norihiro Furusyo, Norihiko Kubo, et al.Journal of Gastroenterology and Hepatology|November 22, 2011
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease StudyEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Journal of Dermatological Science|August 4, 2014
Filaggrin loss-of-function mutations are not a predisposing factor for atopic dermatitis in an Ishigaki Island under subtropical climateTakashi Sasaki, Norihiro Furusyo, Aiko Shiohama, et al.Atherosclerosis|December 22, 2014
Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS)Motohiro Shimizu, Norihiro Furusyo, Fujiko Mitsumoto, et al.Pageof 29